Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
Status:
Unknown status
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Objectives:
To describe the safety and efficacy of intravitreal flucinolone acetonide implants in the
management of patients having refractory ocular Behcet's disease
Hypothesis:
A descriptive observational study
Study design:
A 1-year, multi-center (including four Korean medical centers) observational study
Phase:
Phase 4
Details
Lead Sponsor:
Asan Medical Center
Collaborators:
Kyunghee University Medical Center Samsung Medical Center Seoul National University Hospital